Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials-Reference-Cited by-同舟云学术

Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials

Published:2024-05 Issue: Volume:203 Page:114043
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Raimondi Alessandra,Kim Young Woo,Kang Won Ki,Langley Ruth E.,Choi Yoon Young,Kim Kyoung-Mee,Nankivell Matthew Guy,Randon Giovanni,Kook Myeong-Cherl,An Ji Yeong,Grabsch Heike I.,Prisciandaro Michele,Nichetti Federico,Noh Sung Hoon,Sohn Tae Sung,Kim Sung,Wotherspoon Andrew,Morano Federica,Cunningham David,Lee Jeeyun,Cheong Jae-Ho,Smyth Elizabeth Catherine,Pietrantonio Filippo

Publisher

Elsevier BV

Reference42 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006

3. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial;Bang;Lancet,2012

4. G.A.S.T.R.I.C. (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group X. Paoletti K. Oba T. Burzykowski. et al. Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer: A Meta-Analysis JAMA 303 2010 1729 1737.

5. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial